$IRON

Bolt Metals to Rebrand as 26 Metals Inc. and Adopt the Ticker "IRON," Highlighting Its Focus on Flagship Florália Iron Project in Brazil's Iron Quadrangle

Bolt Metals Corp. will rebrand as 26 Metals Inc. and start trading on the CSE under ticker “IRON” at market open Aug. 19, 2026. The company says it is pivoting to advance its Florália Iron Project in Brazil’s Iron Quadrangle, including plans for drilling, resource work, and environmental permitting. It also appointed Rob Saltsman to the board.

Original reporting
Published Aug 12, 2026, 9:34 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 1:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$IRON
Neutral
medium confidence
Mentioned
$IRON
Relevance
6/10
alphai data visualization · based on accessnewswire.com
Decision brief

The 30-second read

$IRONNeutralMed
01

Why it matters

The key new, time-bound disclosure is the scheduled name and ticker change to 26 Metals Inc. with trading under IRON on the CSE at market open Aug. 19, 2026, alongside ongoing drill and environmental licensing workstreams.

02

Market read

Traders should be prepared for symbol/venue transition effects and monitor follow-on milestones (maiden resource, feasibility-level studies, and environmental permitting) rather than expect immediate fundamental repricing from this release alone.

03

What to watch

Dry processing and impurity claims are presented as evaluation/testwork and management beliefs; traders may need to discount for permitting timelines, metallurgical variability, and capital requirements before development decisions.

Relevance 6/10Novelty 6/10Timing: CSE ticker switch at market open on Aug. 19, 2026

Background

Bolt Metals Corp. (CSE:BOLT) is pivoting to a focused iron development story centered on the Florália Iron Project in Brazil’s Iron Quadrangle.

Company-level read

Ticker impact

$IRONNeutralMedium confidence
Context

The company states it will adopt the ticker symbol IRON on the CSE at market open on Aug. 19, 2026, making the symbol change the core event.

Expected impact

Short-term attention/flow effects around the Aug. 19 open; direction uncertain without accompanying financial or technical results.

Evidence & confidence

This is a corporate action and rebranding announcement with a specific effective date, not a new assay, resource estimate, or financing.

Market effects

Highlights a near-term iron development narrative (high-grade, low-carbon, dry processing) that may influence investor appetite for early-stage iron projects.

Focuses on Brazil’s Iron Quadrangle infrastructure and domestic-first strategy, reinforcing the region’s perceived development readiness.

Low-carbon and sinter-feed positioning could resonate with broader iron ore quality and decarbonization themes, though no new market data is provided.

Counterpoint

The announcement is largely a rebrand and marketing of the Florália thesis; without new drill results, resource updates, or financing terms, price action may fade after the ticker-change event.

Key entities

  • 26 Metals Inc.

    New corporate name for Bolt Metals Corp., with trading to begin under ticker IRON on the CSE on Aug. 19, 2026.

  • Florália Iron Project

    Flagship iron project in Minas Gerais, positioned as high-grade, low-carbon, and potentially suitable for dry magnetic separation.

  • Max Iron Brazil Ltd.

    Option agreement counterparty controlled by Max Resource Corp., granting the right to acquire 100% interest in the Florália High Purity Iron Property.

  • Zachary Kotowych

    CEO and Director who commented on the rebrand and the near-term development plan.

Related articles

$IRONMed

Disc Medicine, Inc. (IRON): Results of Operations and Financial Condition

Disc Medicine, Inc. (IRON) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 iron-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Disc Medicine Reports Second Quarter 2026 Financial Results and Provides Business Update • Completed Type A meeting with the FDA on bitopertin and aligned that the Phase 3 APOLLO study, if successful, can serve as the basis f

$NEEMed

SMALL-CAP MOVERS: Britain's bargain basement and the overseas buyers who can't believe their luck

The article reports AIM takeover activity: Gooch & Housego PLC is being acquired in a £346m deal, and Ramsdens Holdings PLC is set to be bought for £230m. It also notes NextEnergy Solar rose 10% after putting itself up for sale, and highlights large AIM share moves for Ironveld, Itaconix, Jersey Oil and Gas, Safestay, Galileo Resources, and Iofina. Iofina reported 393.3 tonnes H1 2026 and raised guidance to 460-485 tonnes.

$IRONMed

Ironveld shares jump 32% at 0.025p as processing plant hits sustained production

Ironveld PLC (AIM:IRON) shares rose 32% to 0.025p after the company said its dense media separation plant reached sustained production. It now runs 16 hours daily on double shift, processing 2.5-3.5 tonnes per hour and producing 1.4 tonnes/hour in-spec magnetite plus about 1 tonne/hour maghemite. Three clients secured, with a 5,000 tonnes/month buyer sampling; expansion options and Mintek study ongoing.

$IRONMed

Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting

Disc Medicine (NASDAQ:IRON) reported updated clinical data at the 2026 EHA meeting in Stockholm. In RALLY-MF, DISC-0974 showed durable overall anemia responses in myelofibrosis across subgroups, including 55% major hemoglobin response in non-transfusion dependent patients and transfusion independence in 64% (TD Low) and 50% (TD High). In HELIOS, bitopertin sustained PPIX reductions and improved light tolerance with favorable longer-term safety. A corporate call is set for June 15.

$IRONLow

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

Rosen Law Firm said it is investigating potential securities claims for Disc Medicine, Inc. (NASDAQ: IRON) shareholders, alleging materially misleading business information. The firm cited an FDA Complete Response Letter on Feb. 13, 2026 for Disc Medicine’s bitopertin NDA, citing uncertainties needing more evidence; IRON shares fell 22% that day.

$IRONLow

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

Rosen Law Firm said it is investigating potential securities claims for Disc Medicine, Inc. (NASDAQ: IRON) investors over allegations of materially misleading business information. The firm cited an FDA Complete Response Letter on Feb. 13, 2026 for Disc Medicine’s bitopertin NDA, citing uncertainties needing more evidence; IRON shares fell 22% that day.